Drug · DIN 02359073
IPG-RISPERIDONE
Authorized, not yet reported as sold
Authorized for sale in Canada; the company has not yet told Health Canada that it is on the market.
Status Approved since January 19, 2016.
- Drug Identification Number (DIN)
- 02359073
- Company (DIN owner)
- Marcan Pharmaceuticals Inc.Ottawa, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Risperidone N05AX08
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| RISPERIDONE | 1 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- January 19, 2016: NOC 17686Abbreviated New Drug Submission (ANDS) · Merger - buyout
- November 5, 2010: NOC 11851Abbreviated New Drug Submission (ANDS)
Other DINs named IPG-RISPERIDONE
- DIN 02359057 · Approved
- DIN 02359065 · Approved
- DIN 02359081 · Approved
- DIN 02359103 · Approved
- DIN 02359111 · Approved